JPRN-UMIN000028148
Recruiting
Phase 1
The development of treatment using decoded neurofeedback for patients with PTSD - The development of treatment using decoded neurofeedback for patients with PTSD
Osaka Medical and Pharmaceutical University0 sites30 target enrollmentJuly 15, 2017
ConditionsPost-traumatic stress disorder (PTSD)
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Post-traumatic stress disorder (PTSD)
- Sponsor
- Osaka Medical and Pharmaceutical University
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Implanted cardiac pacemaker Surgical aneurysm clips Neurostimulator Implanted pumps Metal fragments in body/eyes Tattoos or permanent eyeliner (if ink contains metallic specks) Treatment history of ECT Diagnosis of neurological disorders (including epilepsy), substance dependence, or significant cardiac disease History of neurological disorders (including epilepsy), substance dependence, or head injury with loss of consciousness Pregnancy. Suspicion of pregnancy. Breast\-feeding. Incapability of contraception during experiment. Doctors diagnose danger.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The development of treatment using the neurofeedback for patients with obsessive-compulsive disorderObsessve-compulsive disorderJPRN-UMIN000013123Graduate School of Medical Science, Kyoto Prefectural University of Medicine20
Recruiting
Not Applicable
Development of treatment for neurological dysfunction using Brain-machine interface based on MEG and EEGeurological dysfunctionJPRN-UMIN000010180Osaka university40
Recruiting
Phase 1
The development of treatment using neurofeedback (NFB) for patients with mood disorderMood disorders (major depressive disorder and bipolar disorder) and healthy volunteersJPRN-jRCTs062180027Okada Go130
Recruiting
Not Applicable
The development of treatment using neurofeedback for patients with mood disorder: an exploratory study through neuroimaging approachesMood disorders (major depressive disorder and bipolar disorder) and healthy volunteersJPRN-UMIN000019483Department of Psychiatry and Neurosciences, Graduate school of Biomedical and Health Sciences, Hiroshima University210
Active, not recruiting
Not Applicable
Development of non-invasive neuromodulation treatment for depressive disorder by violet light- double-blind, randomized, crossover studyMajor depressive disorderDepressionJPRN-jRCTs032210260Kitahata Ryosuke70